Pre-Conference Symposia – International Stroke Conference
Sessions: February 4–6, 2026
Ernest N. Morial Convention Center | New Orleans, Louisiana
A Full Day of Intensive Learning
Our popular Pre-Con Symposia are back once again in 2026! This year, we've added a fourth program, Brain Health, designed to help you deliver the best science to your patients.
Attend these day-long symposia in-person or virtually. Please note: the symposia carry an extra fee for registration.
Pre-Con Symposia
Brain Health Pre-Con Symposium
Feb. 3, 2026
8:45 a.m. to 5:00 p.m. CST
The American Heart Association is launching a new Pre-Conference Symposium on Brain Health, held in conjunction with the International Stroke Conference.
This one-day scientific convening will explore cutting-edge topics at the intersection of vascular neurology, cognitive neuroscience, aging, and public health. Emerging areas such as digital lifestyle interventions, neuroeconomics, and brain capital will be included. Sessions will address the prevention of cognitive decline, the interplay between cardiovascular and brain health, social determinants of brain aging, neuroimaging and biomarker discovery, and scalable interventions to promote lifelong brain health.
The pre-conference will feature multidisciplinary speakers and an engaged audience of investigators and clinicians committed to advancing translational and population-level solutions for brain health and resilience. This event reflects the AHA’s growing commitment to fostering science that supports optimal brain function across the lifespan.
Brain Health Schedule
| Time | Activity |
|---|---|
| 8:45 a.m. to 9:00 a.m. |
Opening Remarks |
| 9:00 a.m. to 10:30 a.m. |
Session 1: The Heart-Brain Connection 9:00 a.m. Cerebral Amyloidosis and the Heart 9:15 a.m. Cardiac Autonomic Dysfunction and Parkinson Disease 9:30 a.m. Atrial Fibriallation and Cognitive Impairment 9:45 a.m. Addressing Brain Health to Improve Heart Failure Outcomes 10:00 a.m. Anxiety, Depression and Hypertension 10:15 a.m. Panel Discussion |
| 10:30 a.m. to 11:00 a.m. | Break |
| 11:15 a.m. to 12:15 p.m. |
Session 2: Post-Stroke Cognitive and Mental Health Problems 11:00 a.m. Epidemiology of Post-Stroke Dementia 11:15 a.m. Infarct-induced neurodegeneration 11:30 a.m. Stroke-Induced Immune Aging 11:45 a.m. Post-stroke Depression 12:00 p.m. Loneliness and Resilience after Life-Changing Events |
| 12:15 p.m. to 1:15 p.m. | Lunch |
| 1:30 p.m. to 3:00 p.m. |
Session 3: Changing the Course of Cognitive Decline and Dementia 1:30 p.m. A Brain Healthy Start: Lifecourse Perspectives on Brain Health 1:45 p.m. Multimodal Interventions to Prevent Dementia 2:00 p.m. Exercise and Brain Health 2:15 p.m. The Neuroscience of Healthy Decision-Making 2:30 p.m. Use of AI to Improve Brain Health 2:45 p.m. Panel Discussion |
| 3:00 p.m. to 3:30 p.m. | Break |
| 3:30 p.m. to 5:00 p.m. |
Session 4: The Brain in Society 3:30 p.m. The Built Environment and the Brain 3:45 p.m. The Musical Brain 4:00 p.m. Creativity and Dementia: Engaging the Arts to Support Persons with Dementia and their Caregivers 4:15 p.m. Brain Capital and the Brain Economy: Investing for the Future 4:30 p.m. Advocating for the Brain 4:45 p.m. Panel Discussion |
HEADS-UP – Health Equity and Actionable Disparities in Stroke: Understanding and Problem-solving
Feb. 3, 2026
8:30 a.m. to 5:45 p.m. CST
This symposium is a multidisciplinary scientific forum focused on race-ethnic disparities in cerebrovascular disease, with the overarching goal of reducing disparities in stroke and accelerating translation of research findings to improve outcomes for race-ethnic minorities who reside in the US. HEADS-UP is a collaborative initiative with the American Stroke Association (ASA), a national organization "dedicated to advancing the science of stroke prevention, treatment and recovery through research and education", and the National Institutes for Neurological Disorders and Stroke (NINDS).
In addition to exciting lectures being given by leaders in this field, twenty early career scholars will present their disparities research work at a dedicated poster session as well as participate in career development sessions. A plenary lecture in honor of the late Edgar Kenton, MD will be given by an outstanding researcher selected by the HEADS-UP Program Committee, with a solid track record of studying or addressing stroke disparities.
| Time | Activity |
|---|---|
| 8:30 a.m. to 9:00 a.m. |
8:30 a.m. Welcome and Policy Speaker Introduction 8:35 a.m. Distinguished Policy Maker Lecture: Scientific Interventions 8:55 a.m. Q&A |
| 9:00 a.m. to 10:00 a.m. |
Session 1: Stroke Clinical Trials and Methods to Study Health Equity 9:00 a.m. Lessons Learned from the design and analysis of RCTs in LMIC countries 9:15 a.m. Strategic Thinking for Stroke Trials in Global Settings: Sustainability and Generalizability 9:30 a.m. Valid Subgroup Analysis in the Context of Trials and Health Equity 9:45 a.m. Panel Discussion |
| 10:00 a.m. to 10:15 a.m. | Break |
| 10:15 to 10:45 a.m. |
10:15 a.m. Introduction of the Edgar J. Kenton III Lecture 10:18 a.m. Kenton Lecture 10:40 a.m. Q&A |
| 10:45 a.m. |
Think Tanks on Works in Progress (Career Development Session) |
| 12:00 p.m. to 1:00 p.m. | Lunch |
| 1:00 p.m. to 1:15 p.m. |
Introduction to the NINDS Speaker 1:05 p.m. NINDS Speaker |
| 1:15 p.m. to 3:15 p.m. |
HEADS-UP Poster Session |
| 3:15 p.m. to 3:30 p.m. | Break |
| 3:30 p.m. to 4:30 p.m. |
Session 2: Center and Network Strategies for Success Amid Adversity 3:30 p.m. Strategies for Success in Health Disparities Research Amid Adversity: Translating Lessons from Other Disciplines to Stroke/Neurology 3:45 p.m. Strategies for Success in Health Disparities Research Amid Adversity: Lessons from NIH-funded Centers and Networks 4:00 p.m. Strategies for Success in Health Disparities Research Amid Adversity: Lessons from NINDS-supported Networks 4:15 p.m. Q&A |
| 4:30 p.m. to 5:30 p.m. |
Building Momentum (Career Development Session) |
| 5:30 p.m. | Closing Remarks, Post-Test & Adjourn Michelle Nichols, Program Vice-Chair |
Stroke in Practice: Stroke Lagniappe (formerly Stroke in the Real World)
Feb. 3, 2026
9:00 a.m. to 5:00 p.m. CST
This symposium is designed to provide cutting edge information for healthcare professionals caring for patients with, or at risk for stroke. This one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. The symposium informs the audience about issues along the full continuum of stroke care and covers varied topics of interest to healthcare providers working in the emergency department, hospitalist settings, primary care, general neurology, pharmacies, and other stroke care arenas. This year’s symposium will focus on addressing challenges in acute stroke management.
| Time | Activity |
|---|---|
| 9:00 to 9:05 a.m. | Welcome Mollie McDermott, MD |
| 9:05 to 10:40 a.m. |
9:05 9:35 10:00 10:25 |
| 10:40 to 10:55 a.m. |
Break |
| 10:55 to 12:15 p.m. |
10:55 11:20 11:45 12:15 |
| 12:30 to 1:30 p.m. |
Lunch |
| 1:30 to 3:05 p.m. |
1:30 2:00 2:25 2:50 |
| 3:05 to 3:20 p.m. | Break |
| 3:20 to 5:00 p.m. |
3:20 3:50 4:15 4:40 4:55 |
Experimental Stroke Science (formerly Stroke in the Lab World)
Feb. 3, 2026
9:00 a.m. to 5:30 p.m. CST
The American Heart Association is hosting the Experimental Stroke Science (formerly Stroke in the Lab World) Pre-Conference, held in conjunction with the International Stroke Conference.
As part of the American Heart Association's growing commitment to fostering science that supports optimal brain function across the lifespan, this pre-conference symposia focuses on promising new developments in the lab and their possible effects on future stroke treatment.
| Time | Activity |
|---|---|
| 9:00 a.m. to 10:00 a.m. |
Session 1: ICH Immunology 9:00 a.m. Role of complement in ICH? 9:15 a.m. Strategies to Enhance Microglia/Macrophages-Mediated Cleanup of Hematoma 9:30 a.m. Inflammation after Spontaneous ICH 9:45 a.m. Myeloid Cell Ferroptosis in Hemorrhagic Stroke 10:00 a.m. Q & A |
| 10:10 a.m. to 10:25 a.m. | Break |
| 10:25 a.m. to 11:35 a.m. |
Session 2: Subarachnoid Hemorrhage 10:25 a.m. Modulation of the TLR4-Lyn interaction in SAH 10:40 a.m. Role of Microthrombi and Inflammation in Delayed Deficits after SAH 10:55 a.m. Roles of NAMPT And NAD+ in Hypoxic Conditioning-Induced 11:10 a.m. Neurovascular Protection by Adropin in Acute Neural Injury from Subarachnoid Hemorrhage 11: 25 a.m. Q & A |
| 11:35 a.m. to 12:45 p.m. |
Session 3: Are Leukocytes Felons in the Brain? 11:35 a.m. Myeloperoxidase (MPO) in Cerebral Injury after SAH 11:50 a.m. Role of Lung-Brain Axis in Advance Age-Associated Damage after ICH 12:05 p.m. Neutrophils in SAH/IVH 12:20 p.m. Advancing a Prognostic and Monitoring Biomarker of Neutrophil-driven Secondary Brain Injury in Spontaneous Intracerebral Hemorrhage for Neurotherapeutics Development |
| 12:45 p.m. to 1:45 p.m. |
Lunch |
| 1:45 p.m. to 2:55 p.m. |
Session 4: ICH pathophysiology 1:45 p.m. Endogenous Zinc Protoporphyrin in Intracerebral Hemorrhage 2:00 p.m. Pathophysiology of Edema in ICH 2:15 p.m. Axonal Degeneration in Hemorrhagic Stroke 2:30 p.m. Epigenetics as Therapeutic Target for Intracerebral Hemorrhage 2:45 p.m. Q & A |
| 2:55 p.m. to 3:10 p.m. | Break |
| 3:10 p.m. to 4:20 p.m. |
Session 5: Amyloid, bAVM and r 3:10 p.m. Role of Endothelium in Pathogenesis of Cerebral Amyloid Angiopathy 3:25 p.m. Gliosis and Vasomotor Coupling in the Setting of CAA 3:40 p.m. Endothelial-to-Mesenchymal Transition in Mutant KRAS-Induced Brain as a Cause of Arteriovenous Malformations 3:55 p.m. Cavernous Malformation Development and Treatment 4:10 p.m. Q & A |
| 4:20 p.m. to 5:30 p.m. |
Session 6: Intraventricular Hemorrhages and Reperfusion Causes of Cerebral Hemorrhage 4:20 p.m. Proinflammatory Immune Cells Disrupt Angiogenesis and Promote Germinal Matrix Hemorrhage in Prenatal Human Brain 4:35 p.m. Leveraging Choroid Plexus M-CSF Signaling to Prevent Inflammatory-Driven Hydrocephalus 4:50 p.m. Role of Choroid Plexus Autotaxin Secretion in Hemorrhage-Induced White Matter Injury 5:05 p.m. Causes and Prevention of Thrombolysis/Reperfusion-Associated Hemorrhages 5:20 p.m. Q&A |